i have accepted the fact that those greenies are a major pain in the ass and this stock will mostly fluctuate between mid 60s and 70s until we get an outcome on the appeals process.
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
